BridgeBio Pharma (BBIO) Prepaid Assets (2019 - 2025)
Historic Prepaid Assets for BridgeBio Pharma (BBIO) over the last 7 years, with Q3 2025 value amounting to $52.4 million.
- BridgeBio Pharma's Prepaid Assets rose 3656.27% to $52.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.4 million, marking a year-over-year increase of 3656.27%. This contributed to the annual value of $34.9 million for FY2024, which is 4346.43% up from last year.
- BridgeBio Pharma's Prepaid Assets amounted to $52.4 million in Q3 2025, which was up 3656.27% from $60.2 million recorded in Q2 2025.
- In the past 5 years, BridgeBio Pharma's Prepaid Assets ranged from a high of $60.2 million in Q2 2025 and a low of $20.5 million during Q2 2023
- Moreover, its 5-year median value for Prepaid Assets was $28.4 million (2024), whereas its average is $31.6 million.
- In the last 5 years, BridgeBio Pharma's Prepaid Assets tumbled by 3727.18% in 2023 and then soared by 11214.26% in 2025.
- BridgeBio Pharma's Prepaid Assets (Quarter) stood at $32.3 million in 2021, then crashed by 32.06% to $21.9 million in 2022, then rose by 10.87% to $24.3 million in 2023, then surged by 43.46% to $34.9 million in 2024, then skyrocketed by 50.26% to $52.4 million in 2025.
- Its Prepaid Assets stands at $52.4 million for Q3 2025, versus $60.2 million for Q2 2025 and $35.4 million for Q1 2025.